Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Targeted Therapies

Skin and breast cancer drugs approved for NHS use in Scotland

An immunotherapy for some patients with advanced skin cancer and a targeted drug for some women with breast cancer have been approved for NHS Scotland.

Three cancer drugs cleared for NHS funding in Scotland

Three cancer drugs have been approved for patients on the NHS in Scotland, including a drug for some patients with advanced liver cancer.

Two targeted lung cancer drugs get initial ‘no’ for NHS in England

Patients with a certain type of lung cancer will not have access to two targeted cancer drugs on the NHS in England.

Advanced breast cancer drug combo approved for NHS in England

A new drug combo has been made available to some patients with advanced breast cancer on the NHS in England.

Targeted lymphoma drug gets green light for NHS in England

People with a certain type of lymphoma will now have access to a targeted cancer drug, called brentuximab vedotin, on the NHS in England.

Drug combination boosts kidney cancer survival in trials

Combining a targeted cancer drug with an immunotherapy extends the lives of advanced kidney cancer patients, according to two clinical trials.

Targeted drug could extend lives of some women with advanced breast cancer

Combining a targeted drug with hormone therapy could extend survival for some women with advanced breast cancer, according to new trial results.

Some people with advanced kidney cancer could avoid surgery

The targeted drug sunitinib is as effective alone as when it’s combined with surgery for some people with advanced kidney cancer.

Six months of breast cancer treatment ‘could be as effective as 12’ in some women with early stage disease

Six months of treatment could be as effective as 12 months for women with a type of early stage breast cancer, according to unpublished clinical trial results.

Precision drug could treat different cancers with rare gene fault  

A new targeted drug could be used to treat a small number of advanced cancers no matter where they grow in the body, according to new trial results.

Pages